Stay updated on CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page.

Latest updates to the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page
- Check3 days agoChange DetectedThe page header now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter revision notes updated to v3.3.3; the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' references were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays a new revision tag: Revision: v3.3.2, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now states that PubMed publications are automatically filled from PubMed and may not be about the study. The revision label was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check61 days agoChange DetectedThe government funding status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe page shows the same study details for NCT02260804 with only minor formatting and layout adjustments; there are no changes to core content such as eligibility criteria, primary outcomes, or reported results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page.